Drug information for KEPIVANCE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
60MCG/KG/DAY
Prescription
PALIFERMIN
Fibroblast Growth Factor 7
BIOVITRUM AB
125103
2011-11-22 Letter
2011-11-21 Label
2011-09-30 Label
2005-12-16 Letter
2005-12-16 Label
2005-09-26 Review
2005-07-28 Other Important Information from FDA
2004-12-29 Letter
2004-12-29 Label
Drug Adverse Effects information for KEPIVANCE
Role code
Indications
Reaction
# Reports
PS
PROPHYLAXIS
DRUG HYPERSENSITIVITY
1
PS
PROPHYLAXIS
DRUG INTOLERANCE
1
PS
PROPHYLAXIS
INFECTION
1
PS
PROPHYLAXIS
MUCOSAL INFLAMMATION
1
PS
PROPHYLAXIS
MULTI-ORGAN FAILURE
1
PS
PROPHYLAXIS
TOXICITY TO VARIOUS AGENTS
1
PS
PROPHYLAXIS
TRANSPLANT FAILURE
1
PS
STOMATITIS
DRUG HYPERSENSITIVITY
1
PS
STOMATITIS
DRUG INTOLERANCE
1
PS
STOMATITIS
INFECTION
1
PS
STOMATITIS
MUCOSAL INFLAMMATION
1
PS
STOMATITIS
MULTI-ORGAN FAILURE
1
PS
STOMATITIS
TOXICITY TO VARIOUS AGENTS
1
PS
STOMATITIS
TRANSPLANT FAILURE
1
Ads by Google